Send mail to Author

Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _____      ___      ______    _____     _____    __   __  
 |__  //    / _ \\   /_   _//  |  ___||  /  ___||  \ \\/ // 
   / //    | / \ ||  `-| |,-   | ||__   | // __     \ ` //  
  / //__   | \_/ ||    | ||    | ||__   | \\_\ ||    | ||   
 /_____||   \___//     |_||    |_____||  \____//     |_||   
 `-----`    `---`      `-`'    `-----`    `---`      `-`'
 


Back to frontdoor view

OPUS4 Logo